Braveheart Bio prices IPO at $18 a share
The offering is expected to deliver $351.2 million in net proceeds.
Braveheart Bio, Inc. priced its initial public offering of 21.25 million shares at $18.00 each.
The company expects estimated net proceeds of $351.2 million. Underwriters also have an option to purchase 3,187,500 additional shares.
Braveheart Bio will have 73,152,838 shares outstanding after the offering, resulting in a market capitalization of $1,316,751,084.